About Steven Hess
Form D filings for OncoVerity from 2022 to 2024 list Steven Hess as director.
Steven Hess first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Steven Hess in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Steven Hess works with at each company, as listed on that company's latest Form D.
OncoVerity, Inc. · Form D, Dec 10, 2024
MC
Massimiliano Colao
Chief Executive Officer and director
AL
Arjen Lemmen
Director
PV
Petra Van Vlierberghe
Director
KM
Kimberly Muller
Director
CS
Clayton Smith
Chief Medical Officer